Navigation Links
Kindred Biosciences Announces Second Quarter 2014 Financial Results
Date:8/13/2014

et loss of $14.3 million, or $0.80 per basic and diluted share compared to a net loss for the six months ended June 30, 2013, of $620,000, or $0.21 per basic and diluted share.  The net loss for the three and six months ended June 30, 2014, includes charges related to stock-based compensation expense of $1.2 million and $2.3 million, respectively, as compared to charges of $59,000 and $98,000 for the comparable periods of 2013, respectively.

The Company had cash, cash equivalents and short-term investments of $112.4 million at June 30, 2014.  For the full year 2014 the Company, reiterating previous guidance, expects operating expenses to be in the range of $25 million to $35 million, excluding the impact of stock-based compensation expense and the impact of acquisitions.  The Company expects stock-based compensation expense for 2014 to be approximately $4.5 million. 

Research and development expense is anticipated to increase for the foreseeable future as the Company continues to increase headcount, commence pivotal studies and further develop its small molecule compounds and biologics development programs.  Due to the inherently unpredictable nature of its development, the Company cannot reasonably estimate or predict the nature, specific timing or estimated costs of the efforts that will be necessary to complete the development of its product candidates.

The Company expects general and administrative expense to increase in the following quarters as it executes plans to commercialize its product candidates, builds its corporate infrastructure and incurs costs associated with being a public company.

Webcast and Conference CallKindredBio will host a conference call today at 4:30 p.m. Eastern Time.
Interested parties may access the call by dialing toll-free (855) 433-0927 from the US, or (484) 756-4262 internationally, and using conference ID 82174423.  The call will also be w
'/>"/>

SOURCE Kindred Biosciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. KindredBio Schedules Release of 2014 Second Quarter Financial Results and Provides Timeline for Release of CereKin Pivotal Study Data
2. Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center
3. Pressure BioSciences, Inc. to Discuss Second Quarter 2014 Financial Results and Provide a Business Update
4. Ambit Biosciences Announces Second Quarter 2014 Operating Results
5. Neurocrine Biosciences Reports Second Quarter 2014 Results
6. Regado Biosciences to Provide Second Quarter 2014 Financial Results and Corporate Highlights
7. Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
8. Ambit Biosciences To Announce Second Quarter 2014 Financial Results
9. Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics Targeted Next Generation Sequencing Testing Platform
10. Attention Regado Biosciences, Inc. Investors: Regado Misled Investors According to a Recently Filed Class Action
11. Meditope Biosciences Appoints Prominent Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Texas , Nov. 26, 2014 ... today announced the completion of previously announced concurrent ... million.  After fees and estimated offering expenses, Lexicon ... the transactions.  The transactions consisted of: ... common stock, pursuant to a registration statement that ...
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Avanir ... that the U.S. Food and Drug Administration (FDA) ... New Drug Application (NDA) for AVP-825. AVP-825 is ... sumatriptan powder delivered intranasally utilizing a novel Breath ... Complete Response letter, and consistent with the preliminary ...
(Date:11/26/2014)... 2014 Investor-Edge has initiated coverage on ... Horizon Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. ... JNJ ), and Theravance Inc. (NASDAQ: THRX ... at: http://investor-edge.com/register . On Tuesday, November 25, ... Dow Jones Industrial Average edged 0.02% lower, to finish the ...
Breaking Medicine Technology:Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Sept. 18 A long-term study found,that a ... with life-threatening,diseases, such as leukemia and lymphoma, results ... males are likely to recover,from these changes over ... In addition, neither male nor female long-term cancer,survivors ...
... Bacterial Infection and May ... Bacterial Infections, BOSTON, Sept. 18 Paratek ... of the Company,s,Multiple Adaptation Response (MAR) inhibitor program. ... controlling virulence and antibiotic,resistance. Paratek has shown that ...
Cached Medicine Technology:Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 2Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 3Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 4Promising Data from Paratek Pharmaceuticals' MAR Inhibitor Program Presented in 'Late Breaker' Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Promising Data from Paratek Pharmaceuticals' MAR Inhibitor Program Presented in 'Late Breaker' Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Promising Data from Paratek Pharmaceuticals' MAR Inhibitor Program Presented in 'Late Breaker' Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4
(Date:11/28/2014)... Mabel’s Labels , the market ... an award-winning company established by four moms, today announced ... Tricia Mumby have been honored with a 2014 RBC ... PROFIT Award for Excellence in Entrepreneurship. , All 4 ... Mumby) accepted the award on behalf of Mabel’s Labels ...
(Date:11/28/2014)... Everett, WA (PRWEB) November 28, 2014 ... Snohomish County provides an overview of the influenza virus that ... annual flu season. , The article begins with a ... it manifests its symptoms. It reminds families that children under ... and those suffering from chronic diseases, such as heart and ...
(Date:11/28/2014)... FL (PRWEB) November 28, 2014 Lice Troopers ... areas of its in-home head lice service for moms ... in the center of Coral Gables on Pone De-leon Blvd ... Bay Harbor Islands that service Miami-Dade & Broward. Lice ... salon in South Florida which has been treating families for ...
(Date:11/28/2014)... Pittsburgh, PA (PRWEB) November 28, 2014 "Most ... have forced me to use crutches," said an inventor from ... better, more convenient way to support my foot, which inspired ... Foot Sling to offer a convenient way to support an ... to get around. It eliminates the need for crutches. The ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Schools ... value of providing quality commercial playground equipment to ... selected APCPLAY© to supply an affordable play structure ... City. , Centra provides comprehensive programs for ... and emotional support services. They have served ...
Breaking Medicine News(10 mins):Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2Health News:Lice Troopers Lice Removal Service Expands in Miami-Dade 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3
... people newly diagnosed with HIV in the UK has ... with the transmission of antiretroviral-resistant HIV. // ... Protection Agency have investigated the connection between two phenomena: ... transmission, and the transmission of drug-resistant HIV. Sexually transmitted ...
... & Melinda Gates Foundation and the Medicines for Malaria ... center //in the United Arab Emirates (UAE). The center ... News reports. ,Gates Foundation and MMV representatives ... of Health to discuss the project. The foundation selected ...
... chances of contracting HIV by up to 60 percent, ... at increased risk of infection. // ,Early results ... potential impact of male circumcision on AIDS in Africa ... sex while healing from circumcision surgery, their female partners ...
... Dry Eye Syndrome (DES) has a significant impact on quality ... and 4.7% of men over 50, and affects over //4.8 ... have been identified, the cause of DES is still largely ... the quantity and/or quality of tears, an unstable tear film, ...
... and type 2 diabetes increases the risk of death for ... of heart disease deaths by itself, but together they’ve been ... an analysis of more than 900 patients with established coronary ... with both type 2 diabetes and symptoms of depression were ...
... of life are not sufficiently met and need to be upgraded ... systems do not reliably meet the needs of people living with ... and Joanne Lynn, two palliative care doctors based in the United ... we use language – and build health care systems – as ...
Cached Medicine News:Health News:STIs Significantly Increase Risk of Drug-resistant HIV Transmission 2Health News:Circumcision May Lift HIV Risk for Women 2Health News:Dry Eye Syndrome Affects Visual Functions 2Health News:Combination of Depression and Type-2-diabetes Lethal for Heart Patients 2Health News:Health Care Systems for Critically Ill Patients Need Restructuring 2
Serrated handle with polished finish. Non-magnetic. Straight tips: Delicate 11 mm. Most popular size or model....
Straight crisscross serrated tips. Flat handle with holes and polished finish....
1 x 2 teeth, cross serrated 5 mm 60 degree angled platform. Round knurled handle with polished finish....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees....
Medicine Products: